





Our team has more than 500 years’ collective experience of delivering innovative end to end GMP biomanufacturing projects, working across three continents.
Whether you are looking to commercialise a research process, develop a fully licensed facility or take your project from donation to delivery, pre-clinical to in-market supply, we are here to support you every step of the way.
From developing manufacturing strategies, processes and GMP facilities to ongoing QP support, we’re very proud of the business and the clients we work with.
We work as part of your team, providing a friendly and confidential service that meets your unique requirements. This approach has enabled us to develop lasting relationships with our clients based on trust and honest collaboration.
We look forward to working with you in the future
We listen. We put your interests first, by ensuring that what we do links with your business strategy. We value knowledge sharing and innovation – free thinking in a structured environment. We like to work as trusted members of an integrated, high performance team. We welcome feedback on our performance.
150+
CLIENTS
Over 150 CGT and biopharma clients
70%
REPEAT BUSINESS
Currently multiple projects with more than 70% of clients
516
INDIVIDUAL PROJECTS
eXmoor has completed over 500 cell therapy and biopharma projects
16
COUNTRIES
eXmoor has completed projects in 16 countries on 4 continents
500
YEARS’ COMBINED EXPERIENCE
eXmoor has a team with around 500 years’ combined experience
37
FACILITY DESIGNS
eXmoor has designed 37 cell & gene therapy and biopharma facilities globally
72
ISOLATORS
eXmoor has specified over 72 isolators for cell & gene therapy facilities globally
8
QP ROLES
eXmoor is currently named on the license as EU QP for 8 facilities
12
CLINICAL TRIALS
eXmoor is involved in 12 clinical trials
250
AMC
eXmoor co-founded the amc to build critical mass and share expertise in ATMP manufacturing; now with 250 fee paying members
Head of QA, Gene Therapy at Great Ormond Street Hospital for Children NHS Foundation Trust
Senior Manager, UK Gene Therapy Company
Head of Biotherapeutics Development Unit, Cancer Research UK